1. Market Research
  2. > Pharmaceutical Market Trends
  3. > CNS Drug News 29 FEBRUARY 2016

CNS Drug News 29 FEBRUARY 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Breakthrough Designation Affirms Ocrelizumab Blockbuster Potential
Industry Brief - LCT Completes Private Placement Of Shares
Industry Brief - Xadago Launched In Spain To Treat Mid- To Late-Stage PD
Industry Trend Analysis - Open Innovation Tools Crucial For Parkinson's Disease Therapy Advancement
Industry Trend Analysis - Billion Dollar Revenues Beckoning For Impax
Industry Brief - ANI And Dexcel Gain Donepezil Approval
Industry Trend Analysis - US Investment Lays MTP Global Expansion Groundwork
Industry Brief - Retrophin's RE-024 Granted European ODD To Treat PKAN
Industry Brief - MultiStem Cell Therapy Phase II Stroke Study Yield Positive Results
Industry Trend Analysis - Novel Drug Delivery Techniques Could Aid MDD Development
Industry Brief - FDA Approves Impax' Mixed Amphetamines ANDA
Industry Brief - Alexza Regains Adasuve US Rights From Teva
Industry Brief - Lannett Gains Sumatriptan Nasal Spray Approval
Industry Brief - Dosing Begins In CAM2038 Phase II Study In Opioid Dependent Patients
Industry Brief - Belbuca Buccal Film Launched In US For Chronic Pain Management
Industry Brief - FDA Breakthrough Therapy Designation For Trevena's Oliceridine
Industry Brief - Adapt Pharma's Narcan Nasal Spray Now Available In US
Industry Brief - Aequus/Supernus Enter Licensing Deal For Trokendi/Oxtellar In Canada
Industry Trend Analysis - Briviact Approval Vital To Retain US Epilepsy Market Position
Industry Brief - Neurelis Finalises Funding To Advance NRL-1 NDA Filing
Industry Brief - FDA Approves Intellipharmaceutics' Levetiracetam
Industry Brief - E Keppra Granted Japanese Approval In Certain Generalised Tonic-Clonic Seizures Patients
Industry Trend Analysis - Mixed Trial Results Will Make Risk Management Key For Future Beloranib Development
Industry Brief - FDA ODD For Remedy's Cirara In Acute SAH/SCI
Industry Trend Analysis - Neuroscience IVDs Remain An Untapped Market
Industry Trend Analysis - Fresh Data Further Undermines Addyi Earnings Potential
Industry Trend Analysis - Rising Trial Risk Will Promote Novel Methods Of Drug Development
Industry Brief - Lightlake Changes Name To Opiant Pharmaceuticals

Table Of Contents

CNS Drug News 29 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.